Harkaeh, S., Qari, Y., Tashkandi, H., Almuhayawi, M., Saber, S. H., aljahdali, E., . . . Mousa, S. (2022). Thymoquinone nanoparticles protect against cisplatin-induced nephrotoxicity in Ehrlich carcinoma model without compromising cisplatin anti-cancer efficacy. Elsevier.
Chicago Style (17th ed.) CitationHarkaeh, Steve, et al. Thymoquinone Nanoparticles Protect Against Cisplatin-induced Nephrotoxicity in Ehrlich Carcinoma Model Without Compromising Cisplatin Anti-cancer Efficacy. Elsevier, 2022.
MLA (8th ed.) CitationHarkaeh, Steve, et al. Thymoquinone Nanoparticles Protect Against Cisplatin-induced Nephrotoxicity in Ehrlich Carcinoma Model Without Compromising Cisplatin Anti-cancer Efficacy. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.